Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lusutrombopag in Relapsed/Chronic ITP
NCT01054443Phase 2Terminated
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lusutrombopag in immune thrombocytopenia (ITP), sponsored by Shionogi & Co., Ltd.. Started Mar 2010; status: terminated.
02
Drugs
lusutrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01054443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054443.